Cargando…
Objectively characterizing Huntington’s disease using a novel upper limb dexterity test
BACKGROUND: The Clinch Token Transfer Test (C3t) is a bi-manual coin transfer task that incorporates cognitive tasks to add complexity. This study explored the concurrent and convergent validity of the C3t as a simple, objective assessment of impairment that is reflective of disease severity in Hunt...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868671/ https://www.ncbi.nlm.nih.gov/pubmed/33555419 http://dx.doi.org/10.1007/s00415-020-10375-8 |
_version_ | 1783648497880268800 |
---|---|
author | Woodgate, Samuel Morgan-Jones, Philippa Clinch, Susanne Drew, Cheney Playle, Rebecca Bennasar, Mohamed Hicks, Yulia Holt, Catherine Bachoud-Lévi, Anne-Catherine Massart, Renaud Craufurd, David Kirby, Nigel Hamana, Katy Schubert, Robin Reilmann, Ralf Rosser, Anne Busse, Monica |
author_facet | Woodgate, Samuel Morgan-Jones, Philippa Clinch, Susanne Drew, Cheney Playle, Rebecca Bennasar, Mohamed Hicks, Yulia Holt, Catherine Bachoud-Lévi, Anne-Catherine Massart, Renaud Craufurd, David Kirby, Nigel Hamana, Katy Schubert, Robin Reilmann, Ralf Rosser, Anne Busse, Monica |
author_sort | Woodgate, Samuel |
collection | PubMed |
description | BACKGROUND: The Clinch Token Transfer Test (C3t) is a bi-manual coin transfer task that incorporates cognitive tasks to add complexity. This study explored the concurrent and convergent validity of the C3t as a simple, objective assessment of impairment that is reflective of disease severity in Huntington’s, that is not reliant on clinical expertise for administration. METHODS: One-hundred-and-five participants presenting with pre-manifest (n = 16) or manifest (TFC-Stage-1 n = 39; TFC-Stage-2 n = 43; TFC-Stage-3 n = 7) Huntington’s disease completed the Unified Huntington’s Disease Rating Scale and the C3t at baseline. Of these, thirty-three were followed up after 12 months. Regression was used to estimate baseline individual and composite clinical scores (including cognitive, motor, and functional ability) using baseline C3t scores. Correlations between C3t and clinical scores were assessed using Spearman’s R and visually inspected in relation to disease severity using scatterplots. Effect size over 12 months provided an indication of longitudinal behaviour of the C3t in relation to clinical measures. RESULTS: Baseline C3t scores predicted baseline clinical scores to within 9–13% accuracy, being associated with individual and composite clinical scores. Changes in C3t scores over 12 months were small ([Formula: see text] ≤ 0.15) and mirrored the change in clinical scores. CONCLUSION: The C3t demonstrates promise as a simple, easy to administer, objective outcome measure capable of predicting impairment that is reflective of Huntington’s disease severity and offers a viable solution to support remote clinical monitoring. It may also offer utility as a screening tool for recruitment to clinical trials given preliminary indications of association with the prognostic index normed for Huntington’s disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-020-10375-8. |
format | Online Article Text |
id | pubmed-7868671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-78686712021-02-09 Objectively characterizing Huntington’s disease using a novel upper limb dexterity test Woodgate, Samuel Morgan-Jones, Philippa Clinch, Susanne Drew, Cheney Playle, Rebecca Bennasar, Mohamed Hicks, Yulia Holt, Catherine Bachoud-Lévi, Anne-Catherine Massart, Renaud Craufurd, David Kirby, Nigel Hamana, Katy Schubert, Robin Reilmann, Ralf Rosser, Anne Busse, Monica J Neurol Original Communication BACKGROUND: The Clinch Token Transfer Test (C3t) is a bi-manual coin transfer task that incorporates cognitive tasks to add complexity. This study explored the concurrent and convergent validity of the C3t as a simple, objective assessment of impairment that is reflective of disease severity in Huntington’s, that is not reliant on clinical expertise for administration. METHODS: One-hundred-and-five participants presenting with pre-manifest (n = 16) or manifest (TFC-Stage-1 n = 39; TFC-Stage-2 n = 43; TFC-Stage-3 n = 7) Huntington’s disease completed the Unified Huntington’s Disease Rating Scale and the C3t at baseline. Of these, thirty-three were followed up after 12 months. Regression was used to estimate baseline individual and composite clinical scores (including cognitive, motor, and functional ability) using baseline C3t scores. Correlations between C3t and clinical scores were assessed using Spearman’s R and visually inspected in relation to disease severity using scatterplots. Effect size over 12 months provided an indication of longitudinal behaviour of the C3t in relation to clinical measures. RESULTS: Baseline C3t scores predicted baseline clinical scores to within 9–13% accuracy, being associated with individual and composite clinical scores. Changes in C3t scores over 12 months were small ([Formula: see text] ≤ 0.15) and mirrored the change in clinical scores. CONCLUSION: The C3t demonstrates promise as a simple, easy to administer, objective outcome measure capable of predicting impairment that is reflective of Huntington’s disease severity and offers a viable solution to support remote clinical monitoring. It may also offer utility as a screening tool for recruitment to clinical trials given preliminary indications of association with the prognostic index normed for Huntington’s disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-020-10375-8. Springer Berlin Heidelberg 2021-02-08 2021 /pmc/articles/PMC7868671/ /pubmed/33555419 http://dx.doi.org/10.1007/s00415-020-10375-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Communication Woodgate, Samuel Morgan-Jones, Philippa Clinch, Susanne Drew, Cheney Playle, Rebecca Bennasar, Mohamed Hicks, Yulia Holt, Catherine Bachoud-Lévi, Anne-Catherine Massart, Renaud Craufurd, David Kirby, Nigel Hamana, Katy Schubert, Robin Reilmann, Ralf Rosser, Anne Busse, Monica Objectively characterizing Huntington’s disease using a novel upper limb dexterity test |
title | Objectively characterizing Huntington’s disease using a novel upper limb dexterity test |
title_full | Objectively characterizing Huntington’s disease using a novel upper limb dexterity test |
title_fullStr | Objectively characterizing Huntington’s disease using a novel upper limb dexterity test |
title_full_unstemmed | Objectively characterizing Huntington’s disease using a novel upper limb dexterity test |
title_short | Objectively characterizing Huntington’s disease using a novel upper limb dexterity test |
title_sort | objectively characterizing huntington’s disease using a novel upper limb dexterity test |
topic | Original Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868671/ https://www.ncbi.nlm.nih.gov/pubmed/33555419 http://dx.doi.org/10.1007/s00415-020-10375-8 |
work_keys_str_mv | AT woodgatesamuel objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT morganjonesphilippa objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT clinchsusanne objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT drewcheney objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT playlerebecca objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT bennasarmohamed objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT hicksyulia objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT holtcatherine objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT bachoudleviannecatherine objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT massartrenaud objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT craufurddavid objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT kirbynigel objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT hamanakaty objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT schubertrobin objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT reilmannralf objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT rosseranne objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest AT bussemonica objectivelycharacterizinghuntingtonsdiseaseusinganovelupperlimbdexteritytest |